drugset / Trial / NCT00829374
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine if Dimebon is safe and effective in patients with mild to moderate Alzheimer's disease on Donepezil.
Timeline
- Start
- 2009-03
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Latrepirdine | Small molecule | 5 mg | Oral |
| Subject | Latrepirdine | Small molecule | 20 mg | Oral |